Skip to Main Content

Author Details

Frances T Hakim
National Cancer Institute
1984
101
43
PMIDPaper TitleJournal TitlePublished Year
37129971Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.JCI Insight2023
37129971Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.JCI Insight2023
35114411Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.Transplant Cell Ther2022
36348353Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients.J Transl Med2022
35878742Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus Criteria.Transplant Cell Ther2022
35114411Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.Transplant Cell Ther2022
34875023Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.Rheumatology (Oxford)2022
36348353Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients.J Transl Med2022
35878742Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus Criteria.Transplant Cell Ther2022
34875023Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.Rheumatology (Oxford)2022
32976576A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.Blood2021
32976576A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.Blood2021
34433916Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.Bone Marrow Transplant2021
35005541Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease.iScience2021
35005541Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease.iScience2021
34433916Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.Bone Marrow Transplant2021
31903638Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.Am J Hematol2020
31903638Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.Am J Hematol2020
29367715Biomarkers in chronic graft-versus-host disease: quo vadis?Bone Marrow Transplant2018
29367715Biomarkers in chronic graft-versus-host disease: quo vadis?Bone Marrow Transplant2018
29812997T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.J Clin Oncol2018
29812997T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.J Clin Oncol2018
27713092The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.Biol Blood Marrow Transplant2017
28851699An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.Blood2017
28756593Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide.J Neurooncol2017
28437849Clinical significance of IgE in a large cohort of patients with moderate or severe chronic graft-versus-host disease.Am J Hematol2017
27899803Novel targets in the treatment of chronic graft-versus-host disease.Leukemia2017
27796910Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin.AAPS J2017
27713092The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.Biol Blood Marrow Transplant2017
28437849Clinical significance of IgE in a large cohort of patients with moderate or severe chronic graft-versus-host disease.Am J Hematol2017
28756593Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide.J Neurooncol2017
28851699An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.Blood2017
27796910Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin.AAPS J2017
27899803Novel targets in the treatment of chronic graft-versus-host disease.Leukemia2017
26811520Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.J Clin Oncol2016
26811520Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.J Clin Oncol2016
27179943Erratum to "Salivary Gland Involvement in Chronic Graft-versus-Host Disease: Prevalence, Clinical Significance, and Recommendations for Evaluation" [Biol Blood Marrow Transplant 16:1362-1369].Biol Blood Marrow Transplant2016
27412889T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.Blood2016
27118572Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease.Biol Blood Marrow Transplant2016
27694491Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.J Immunol2016
27694491Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.J Immunol2016
27118572Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease.Biol Blood Marrow Transplant2016
27412889T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.Blood2016
27179943Erratum to "Salivary Gland Involvement in Chronic Graft-versus-Host Disease: Prevalence, Clinical Significance, and Recommendations for Evaluation" [Biol Blood Marrow Transplant 16:1362-1369].Biol Blood Marrow Transplant2016
25532725Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo.Stem Cells2015
25532725Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo.Stem Cells2015
25771402Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.Biol Blood Marrow Transplant2015
25644957National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.Biol Blood Marrow Transplant2015
26071480High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses.Clin Cancer Res2015
26071480High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses.Clin Cancer Res2015
  • 1 - 50 of 202

Recommended Authors

Jordi Ochando
Icahn School of Medicine at Mount Sinai
Career Start Year 2004
Number of shared co-authors 0
Robert S Welner
University of Alabama at Birmingham
Career Start Year 2002
Number of shared co-authors 0
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 0
Dorian LaTocha
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2000
Number of shared co-authors 0
Miriam Merad
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 1
Xingmin Feng
and Blood Institute, National Institutes of Health
Career Start Year 1999
Number of shared co-authors 4
Evan F Lind
Oregon Health & Science University
Career Start Year 1999
Number of shared co-authors 0
Andrew D Wells
Center for Spatial and Functional Genomics, Children's Hospital of Philadelphia
Career Start Year 1996
Number of shared co-authors 0
Jichun Chen
and Blood Institute, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 2
Chance John Luckey
University of Virginia School of Medicine.
Career Start Year 1995
Number of shared co-authors 1
Hiroshi Kawamoto
Institute for Life and Medical Sciences, Kyoto University
Career Start Year 1991
Number of shared co-authors 1
Volker Eckstein
Heidelberg University
Career Start Year 1990
Number of shared co-authors 0
Qi Wu
University of Michigan Medical School
Career Start Year 1989
Number of shared co-authors 0
Mary M Tomayko
Yale University School of Medicine
Career Start Year 1988
Number of shared co-authors 0
Drake Laface
Merck & Co. Inc.
Career Start Year 1987
Number of shared co-authors 0
Maura Rossetti
University of California Los Angeles
Career Start Year 1986
Number of shared co-authors 0
Denis-Claude Roy
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 2
Su M Metcalfe
University of Cambridge Clinical School, LIFNanoRx Ltd
Career Start Year 1984
Number of shared co-authors 0
Richard T Maziarz
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 5
Penelope A Morel
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 0
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 2
Louis J Picker
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 1
Wolfgang Holter
St. Anna Children's Hospital, Medical University of Vienna
Career Start Year 1980
Number of shared co-authors 0
Helen C O'Neill
UCL Institute for Women's Health, University College London
Career Start Year 1979
Number of shared co-authors 0
Leonard D Shultz
The Jackson Laboratory Cancer Center
Career Start Year 1971
Number of shared co-authors 3
Ronald N Germain
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1971
Number of shared co-authors 2
Ellen R Richie
The University of Texas MD Anderson Cancer Center
Career Start Year 1970
Number of shared co-authors 2
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 1
Shigeo Koyasu
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 1
David W Scott
University of British Columbia
Career Start Year 1965
Number of shared co-authors 3

Collaborators

Ronald E Gress
National Cancer Institute, National Institutes of Health
Co-authored papers 57
Steven Z Pavletic
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 35
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 23
Daniel H Fowler
National Cancer Institute, National Institutes of Health
Co-authored papers 22
Jeremy J Rose
National Cancer Institute
Co-authored papers 20
Edward W Cowen
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Co-authored papers 14
Gene M Shearer
Co-authored papers 12
Sarfraz Memon
Center for Cancer Research, National Cancer Institute.
Co-authored papers 11
Kristin Baird
National Cancer Institute, National Institutes of Health
Co-authored papers 8
Jacqueline W Mays
National Institute of Dental and Craniofacial Research, National Institutes of Health
Co-authored papers 7
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 6
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Co-authored papers 6
David C Halverson
National Cancer Institute, National Institutes of Health
Co-authored papers 6
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Matin M Imanguli
Rutgers Robert Wood Johnson Medical School
Co-authored papers 5
William G Telford
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Susan Dhamala
National Institute of Dental and Craniofacial Research
Co-authored papers 3
Sophie Paczesny
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 3
Xiao-Yi Yan
Liaoning Normal University
Co-authored papers 3
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 2
Kouros Owzar
Duke University
Co-authored papers 2
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Liang Cao
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Najibah Rehman
Cincinnati Children's Hospital Medical Center
Co-authored papers 2
Stefania Pittaluga
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Edna Mozes
Co-authored papers 1
Robert B Nussenblatt
National Eye Institute
Co-authored papers 1
Elizabeth C Jones
Clinical Center, National Institutes of Health
Co-authored papers 1
Matthias Edinger
Regensburg University Hospital
Co-authored papers 1
Roel Vermeulen
Co-authored papers 1
Release 1.2